CORT Corcept Therapeutics Incorporated
CORT Corcept Therapeutics Incorporated
Healthcare · Biotechnology
Market read
Scan convergence 1 scan as of 2026-10-16 1 neutral converging
POC $34.77 · VWAP $65.11 · +69.2% vs 12m avg buyer
Insiders selling 0 buy / 1 sell · Form 4, 90d $12.3M sold last open-market sell MAHONEY DAVID L
Cluster Director, Officer + 3 others sold $7.6M, Aug 5–18
Coverage
1 watchlist
CORT Price Structure
Loading timeframes…
Peers
Every watchlist CORT belongs to, members best 30-day change first — CORT highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@monster-discoveries
Reported the quarter ending 2026-06-30: revenue $256M, diluted EPS $0.36, net income $43M (SEC filing). Across the print the stock moved +23.2% (close before → first close after).
full note →Against street estimates
How CORT's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
CORT research tape
88 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.